Restricted accessResearch articleFirst published online 1995-4
L'analisi del DNA mediante citometria a flusso nei tumori superficiali della vescica: DNA analysis through flow cytometry in superficial bladder tumours
The aim of this work is to try to characterize the prognostic value of DNA flow cytometry in superficial bladder tumours and to try to indicate this investigation in clinical practice. The Authors review results reported in literature and those relative to their experience. Data investigation shows that this test has prognostic significance because it is correlated with the stage and grade of the tumour. The correlation with the clinical development of the tumour is not clear in the Authors’ experience. The Authors think that flow cytometry does not have a precise role in clinical practice.
TribukaitB.: Flow cytometry in surgical pathology and cytology of tumours of genito-urinary tract. Advances in clinical cytology, KossL.G., and ColemanD.V. eds., Masson Publ. Co. USA Inc., Vol. 2, cap. 8, p. 163–189, 1984.
2.
MobilioG., TribukaitB., FranzolinN., AzzolinaL.S., TridenteG., BianchiG., BeltramiP., CurtiP.: Prognosis of superficial bladder tumours as studied by DNA flow cytometry. Report on a double blind study of 120 patients. J. Exp. Clin. Cancer Res., 7: 243, 1988.
3.
FranzolinN., BianchiG., MalossiniG., NovellaG., AzzolinaL.S., ComunaleL., MobilioG.: Valutazione comparativa tra citologia ed analisi citofluorimetrica del DNA nucleare del liquido di lavaggio delle neoplasie vescicali. Acta Urol. Ital., 4(Suppl. 1): 497, 1989.
4.
BlomjousC.E.M.: Retrospective study of prognostic importance of DNA flow cytometry of urinary bladder carcinoma. J. Clin. Pathol., 41: 21, 1988.
5.
PetersenS.E.: Accuracy and reliability of flow cytometric DNA analysis a simple, one-step ethidium-bromide staining protocol. Cytometry, 7: 301, 1986.
6.
FranzolinN., BeltramiP., PianonR., AzzolinaL.S., ComunaleL., BianchiG., MobilioG.: Confronto tra criopreservazione e fissazione in etanolo di biopsie vescicali e prostatiche per l'analisi citofluorimetrica del DNA. Acta Urol. Ital., 6(Suppl. 1): 371, 1990.
7.
CarateroC., HijaziA., CarateroA., MazerollesC., RischmannP.: Flow cytometry analysis of urothelial cell DNA content according to pathological and clinical data on 100 bladder tumours. Eur. Urol., 18: 145, 1990.
8.
VerineJ.L., CoicH., BertrandG., LepinardV., SoretJ.Y.: Intéret pronostique de la cytofluorometrie dans les tumeurs vésicales. Ann. Urol. (Paris), 20: 175, 1986.
9.
ChinJ., HuberR., NavaE., RustumY., GrecoJ., PontesJ., FrankfurtO.: Flow cytometric analysis of DNA content in human bladder tumours and irrigation fluids. Cancer, 56: 1677, 1985.
10.
KleinF.A., HerrH.W., WhitmoreW.F., SoganiP.C., MelamedM.R.: An evaluation of automated flow cytometry (FCM) in detection of carcinoma in situ of the urinary bladder. Cancer, 50: 1003, 1982.
11.
LipponenP.K., EskelinenM.J., NordlingS.: Progression and survival in transitional cell bladder cancer: a comparison of established prognostic factors, S-phase fraction and DNA ploidy. Eur. J. Cancer, 27: 877, 1991.
12.
NormingU., NymanC.R., TribukaitB.: Comparative histopathology and deoxyribonucleic acid flow cytometry of random mucosal biopsies in untreated bladder carcinoma. J. Urol., 145: 1164, 1991.
13.
CampanellaR., RussoA., PlajaS., BazanV., PavoneC., CorselliG., Pavone-MacalusoM.: Study of cellular DNA content by flow cytometry in primary bladder carcinomas. Eur. Urol., 21: 58, 1992.
14.
MalmströmP.U., VaskoJ., WesterK., NorlenB.J., BuschC.: Flow cytometry analysis of DNA content of deparaffinized nuclei in urinary bladder carcinomas. APMIS, 97: 811, 1989.
15.
De SiatiM., GrassiD., FranzolinN., MarchiorettoF., AzzolinaL.S.: Citometria di flusso nei tumori della vescica: la nostra esperienza. Urologia, 60: 158, 1993.
16.
BadalamentR.A., KimmelM., GayH., CibasE.S.: The sensitivity of flow cytometry compared with conventional cytology in the detection of superficial bladder carcinoma. Cancer, 59: 2078, 1987.
17.
NormingU., TribukaitB., GustafsonH., NymanC.R., WangN., WijkstromH.: Deoxyribonucleic acid profile and tumour progression in primary carcinoma in situ of the bladder: a study of 63 patients with grade 3 lesions. J. Urol., 147: 11, 1992.
18.
MurphyW., ChandlerR.W., TraffordR.M.: Flow cytometry of deparaffinized nuclei compared to histological grading for the pathological evaluation of transitional cell carcinoma. J. Urol., 135: 694, 1986.
19.
Di SilverioF., TenagliaR., De VitaR., De MatteisA.: Valutazione clinica del rapporto tra ploidia citometrica e grading delle neoplasie urologiche. Acta Urol. Ital., 1: 17, 1987.
20.
De VitaR., ForteD., MaggiF., EleuteriP., Di SilverioF.: Cellular DNA content and proliferative activity evaluated by flow cytometry versus histopathological and staging classifications in human bladder tumours. Eur. Urol., 19: 65, 1991.
21.
TribukaitB.: Flow cytometry in assessing the clinical aggressiveness of genito-urinary neoplasm. World J. Urol., 5: 108, 1987.
22.
LipponenP.K., NordlingS., EskelinenM.J., JauhiainenK., TerhoR., HarjuE.: Flow cytometry in comparison with mitotic index in predicting disease outcome in transitional-cell bladder cancer. Int. J. Cancer, 53: 42, 1993.
23.
BlomjousC.E.M., SchipperN.W., BaakJ.P.A., VosW., De VoogtH.J., MejjerC.J.L.: The value of morphometry and DNA flow cytometry in addition to classic prognosticators in superficial urinary-bladder carcinoma. Am. J. Pathol., 91: 243, 1989.
24.
GustafsonH., TribukaitB., EspostiP.L.: DNA pattern, histological grade and multiplicity related to recurrence rate in superficial bladder tumours. Scand. J. Urol. Nephrol., 16: 135, 1982.
25.
Di SilverioF., Von HelandM., De BernardisE., IzziR., BuscarmiM., De VitaR., ForteR., SeccarecciaF., MenottiA.: Prognostic role of flow cytometry in superficial bladder cancer. Eur. Urol., 21(Suppl. 1): 22, 1992.
26.
GustafsonH., TribukaitB., EspostiP.L.: DNA profile and tumours progression in patients with superficial bladder tumours. Urol. Res., 10: 13, 1982.
27.
MastersJ.R.W., CamplejohnR.S., Constance-ParkinsonM., WoodhouseC.R.J.: DNA ploidy and the prognosis of stage pT1 bladder cancer. Br. J. Urol., 64: 403, 1989.
28.
GustafsonH., TribukaitB., EspostiP.L.: The prognostic value of DNA analysis in primary carcinoma in situ of the urinary bladder. Scand. J. Urol. Nephrol., 16: 141, 1982.
29.
De Vere WhiteR., DeitchA., WestB., FitzpatrickJ.: The predictive value of flow cytometric information in the clinical management of stage 0 (Ta) bladder cancer. J. Urol., 139: 279, 1988.
30.
LipponenP.K., EskelinenM.J., JauhiainenK., TerhoR., NordlingS.: Proliferation indices as independent prognostic factors in papillary Ta-T1 transitional cell bladder tumours. Br. J. Urol., 72: 451, 1993.
31.
WheelessL.L., BadalamentR.A., De Vere WhiteR.W., FradetY., TribukaitB.: Consensus review of the clinical utility of DNA cytometry in bladder cancer. Cytometry, 14: 478, 1993.
32.
MalmströmP.U.: Prognosis of transitional cell bladder carcinoma with special reference to ABH blood group isoantigen expression and DNA analysis. Scand. J. Urol. Nephrol., 1(Suppl. 112): 32, 1988.
33.
TachibanaM., DeguchiN., BabaS., JitsukawaS., HataM., TazakiH.: Multivariate analysis of flow cytometric deoxyribonucleic acid parameters and histological features for prognosis of bladder cancer patients. J. Urol., 146: 1530, 1991.
34.
MurphyW.M., ChandlerR.W., TraffordR.M.: Flow cytometry of deparaffinized nuclei compared to histological grading for the pathological evaluation of transitional cell carcinomas. J. Urol., 135: 694, 1986.
35.
PauwelsR., SmeetsA., SchapersR., BeckH.: Are cytoflowmetry or chromosome studies or other predictors of any help determining the prognosis of low-grade superficial tumours?Therapeutic Progress in Urological Cancers., 503, 1989.
36.
Sanchez-FernandezM.C., Gil-SalomonM., Perez-BaceteM., Morell-QuadrenyL., Martinez-DiazF., Iborra-JuanI., Fenollosa-EntrenaB., Llombart-BoschA.: DNA-ploidy, morphometric-stereological and P-Glycoprotein study of superficial bladder carcinomas. Eur. Urol., 21(Suppl. 1): 16, 1992.
37.
BrettonP.R., HerrH.W., KimmelM., FairW.R., WhitemoreW.F., MelamedM.R.: Flow cytometry as a predictor of response and progression in patients with superficial bladder cancer treated with bacillus Calmette-Guerin. J. Urol., 141: 1332, 1989.
38.
FranzolinN., BianchiG., ComunaleL., D'AmicoA., NovellaG., AzzolinaL.S., MobilioG.: Valutazione citofluorimetrica del DNA dell'urotelio nei tumori superficiali della vescica prima e dopo terapia antiblastica endocavitaria. Acta Urol. Ital., 6(Suppl. 1): 367, 1990.
